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Abstract
Mitral Valve Disease (MVD) describes a variety of pathologies that result in regurgitation
of blood during the systolic phase of the cardiac cycle. Decisions in valvular disease man-
agement rely heavily on non-invasive imaging. Transesophageal echocardiography (TEE) is
widely recognized as the key evaluation technique where backflow of high velocity blood can
be visualized under Doppler. In most cases, TEE imaging is adequate for identifying mitral
valve pathology, though the modality is often limited from signal dropout, artifacts and a re-
stricted field of view. Quantitative analysis is an integral part of the overall assessment of valve
morphology and gives objective evidence for both classification and guiding intervention of
regurgitation. In addition, patient-specific models derived from diagnostic TEE images allow
clinicians to gain insight into uniquely intricate anatomy prior to surgery. However, the heavy
reliance on TEE segmentation for diagnosis and modelling has necessitated an evaluation of
the accuracy of the oft-used mitral valve imaging modality.
Dynamic cardiac 4D-Computed Tomography (4D-CT) is emerging as a valuable tool for
diagnosis, quantification and assessment of cardiac diseases. This modality has the potential
to provide a high quality rendering of the mitral valve and subvalvular apparatus, to provide
a more complete picture of the underlying morphology. However, application of dynamic
CT to mitral valve imaging is especially challenging due to the large and rapid motion of the
valve leaflets. It is therefore necessary to investigate the accuracy and level of precision by
which dynamic CT captures mitral valve motion throughout the cardiac cycle. To do this,
we design and construct a silicone and bovine quasi-static mitral valve phantom which can
simulate a range of ECG-gated heart rates and reproduce physiologic valve motion over the
cardiac cycle. In this study, we discover that the dynamic CT accurately captures the underlying
valve movement, but with a higher prevalence of image artifacts as leaflet and chordae motion
increases due to elevated heart rates.
In a subsequent study, we acquire simultaneous CT and TEE images of both a silicone
mitral valve phantom and an iodine-stained bovine mitral valve. We propose a pipeline to use
CT as the ground truth to study the relationship between TEE intensities and the underlying
valve morphology. Preliminary results demonstrate that with an optimized threshold selection
based solely on TEE pixel intensities, only 40% of pixels are correctly classified as part of the
valve. In addition, we show that emphasizing the centre-line rather than the boundaries of high
intensity TEE image regions provides a better representation and segmentation of the valve
morphology. This work has the potential to inform and augment the use of TEE for diagnosis
and modelling of the mitral valve in the clinical workflow for MVD.
Keywords: Mitral Valve Disease, Transesophageal Echocardiography, Dynamic 4D-CT.
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Chapter 1
Introduction
1.1 Background
This chapter consists of a general overview of the anatomy and physiology of the human heart,
with special attention given to the mitral valve. As well, this introductory section outlines the
current standard of care for imaging, diagnosis and intervention of mitral valve disease, and
previous work that is pertinent to the core focus of this thesis. Heart disease has become the
number one cause of global death, with one in four deaths attributed to cardiovascular compli-
cations. The economic impact of treating cardiovascular diseases is significant, costing $320.1
billion USD annually, with the total number of cardiac operations and procedures increasing
by 28% over the last twenty years [49]. With the significant increase in life expectancy over
the past century, valvular heart disease has been referred to as the next cardiac epidemic [12]
and deadliest plague [29] facing modern medicine. Transesophageal echocardiography (TEE)
is widely recognized as the standard of care evaluation technique to diagnose mitral valve dis-
ease (MVD). In most cases, TEE imaging is adequate for identifying pathology, however due
to limitations such as signal dropout, limited resolution and user-variability in interpreting im-
ages, the diagnostic value of TEE is often limited. A study of 242 patients who had undergone
TEE-guided mitral valve repair for degenerative mitral valve disease found the rate of recur-
rence of mitral valve regurgitation to be 5% after 1 month and 40% after 4 years [19]. To meet
the current demand for innovative solutions to cardiovascular issues, medical companies have
been developing a wide range of devices, tools, imaging systems and techniques for improved
diagnosis and intervention. Conventional open-heart cardiac surgery is often too invasive and
not feasible for the aging population. A recent US study estimates the prevalence of valvular
heart disease (VHD) to be 2.5% progressively increasing with age up to 13.2% at 75 years of
age [51]. Conversely, beating-heart surgery employs image-guided, minimally-invasive tools
to repair and replace heart valves while minimizing procedural patient trauma [22]. To develop
1
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these techniques, dynamic cardiac simulators are needed for testing, validation and surgical
training; referred to as phantoms, these simulators remove the need for multiple animal studies
and expedite the implementation of ideas from the lab bench to the operating room. However,
no two valves function or fail in the same manner. Cardiac surgeons have identified a need for
patient-specific valve models in their preparation for minimally-invasive procedures [33]. This
work was motivated by the increasing complexity of diagnosis and treatment of mitral valve
regurgitation. Dynamic cardiac computed tomography (CT) is emerging as a valuable tool for
diagnosis and assessment of cardiac function. We have conducted various studies to investi-
gate the accuracy of dynamic CT for diagnosis and patient-specific modelling of mitral valve
regurgitation. In addition, we have used dynamic CT as a ground truth to assess the efficacy
of trans-esophageal ultrasound for accurately capturing valve morphology and motion. It is
our aspiration that the outcome of this thesis will provide clinicians with the ability to better
diagnose, model and address problems with the mitral valve.
Figure 1.1: Cardiac Chambers (Image Courtesy of The Cardio Research Web Project)
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1.2 Anatomy and Physiology of the Human Heart
1.2.1 Overview of Anatomy and Circulation
The heart is a muscular organ central to the distribution of blood through a vast network of
arteries and veins that comprise the cardiovascular system. This enables systemic circulation
of oxygen and nutrients to the tissues, along with removal of carbon dioxide and other wastes.
Divided into four chambers, blood from the venous system is received at the right atrium,
travels to the right ventricle where it is pumped to the lungs to be oxygenated. The left atrium
then receives oxygen-rich blood from the lungs, which is pumped to the left ventricle and then
through the aorta into systemic circulation (Figure 1.1).
1.2.2 Electrical Activity of the Heart
An electrocardiogram (ECG) is acquired from strategically-placed electrodes on the patients
limbs and records the electrical activity of the heart (Figure 1.2). A new ECG waveform
is produced for each cardiac cycle. The first stage of the ECG is the P-wave, representing
atrial depolarization. The PR interval tracks the start of the P-wave to the start of the Q-
wave, indicating the time taken for the electrical signals to be conducted between the atria
and ventricles. The QRS complex covers the depolarization of the ventricles, as seem by
three related waves (Q, S and R waves). Next, the ST-segment begins after the S-wave and
finishes at the start of the T-wave; this period represents the time between depolarization and
repolarization of the ventricles. During the T-wave, ventricular repolarization occurs.
Figure 1.2: ECG waveform which tracks the electrical activity of the heart divided into the P, QRS and
T waves (Image Courtesy of EKG Academy)
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Other terminology used to characterize the ECG wave is the R-R interval, which starts
at the peak of one R wave and ends at the peak of the subsequent R-wave, denoting the time
between two QRS complexes. As well, the QT-interval outlines the time taken for the ventricles
to depolarize and repolarize, starting at the beginning of the QRS complex and finishing at the
end of the T-wave [34].
The overall cardiac cycle can be divided into two distinct phases of electrical activity: (1)
diastole and (2) systole. During diastole, the ventricles are relaxed and for most of this period,
blood flows passively from the left and right atria to the left and right ventricles, respectively.
To achieve this flow pattern, blood passes through the atrioventricular valves (mitral on the left
and tricuspid on the right) which separate atria and ventricles. Systole is the time of simulta-
neous left and right ventricular contraction when blood is ejected to the aorta and pulmonary
artery, respectively (Figure 1.3). During systole, the atrioventricular valves are closed to ensure
one-way, forward motion of blood, while the aortic and pulmonary valves are opened [66].
1.2.3 Heart Valves
The movement and direction of blood flow through the four chambers are regulated by four
heart valves. The tricuspid valve separates the right atrium and ventricle, while the pulmonary
valve sits between the right ventricle and the pulmonary artery. On the left side of the heart,
the mitral valve directs blood flow between the atrium and ventricle, while the aortic valve
separates the ventricle and aorta (Figure 1.4). Under normal circumstances, blood flow is
Figure 1.3: Blood flow through the heart chambers and valves during diastole and systole (Image Cour-
tesy of Cardiovascular Physiology Concepts)
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unidirectional through the heart, entering the right atrium and rejoining systemic circulation
after passing through the left ventricle. This flow pattern is facilitated by heart valves which
act as one-way inlets of blood on one side of the ventricle and one-way outlets of blood on the
other ventricular side. When heart muscle contracts and relaxes over the length of the cardiac
cycle, the valves open and shut, directing and alternating blood flow through the four chambers.
Heart valves can malfunction in two ways: (1) regurgitation and (2) stenosis. A regurgitant
valve does not close completely, causing backflow of blood into the preceding chamber rather
than forwards through the valve. In a stenotic valve, the opening was either formed incorrectly
or has become narrowed such that blood flow is impeded; as a result, the heart must pump
blood with greater force to move blood through the stiff, stenotic valve [65].
Figure 1.4: Cardiac Valves (Image Courtesy of The Cardio Research Web Project)
Chapter 1. Introduction 6
1.2.4 The Mitral Valve
The mitral valve (MV) separates the left atrium and ventricle, and is the main anatomical focus
of this thesis. Embryologic development of the mitral valve is a complex process, which occurs
in the endocardial cushion between the fifth and fifteenth weeks of gestation. As one of the
most unique tissues in the human body, mitral valve structure is highly variable. The fully
developed valve complex comprises an annulus, two valve leaflets (posterior and anterior),
chordae tendineae, and papillary muscles (Figure 1.5). Peripheral to the valve apparatus are
the walls of the left atrium and ventricle. The non-planar, saddle-shaped valve complex is
obliquely located in the heart, immediately adjacent to the aortic valve [32].
Figure 1.5: Components of the Mitral Valve (Image Courtesy of Medscape)
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The mitral annulus describes the tissue juncture of the endocardial layer of the left atrium,
the valve tissue, and the endocardium and myocardium of the ventricle [68]. Mitral valve
leaflets (posterior and anterior) are distinctly different in circumference and shape to the leaflets
of the other atrioventricular valve, the tricuspid valve. Along with the leaflets, the valve has
variable, accessory tissue termed commissural scallops to occlude medial and lateral gaps dur-
ing leaflet coaptation. In a normal, healthy state, mitral valve leaflets are thin, soft, pliable
and translucent. Both leaflets have an atrial and ventricular surface. The posterior leaflet is
crescent-shaped with a short radial length and long circumferential base; to facilitate clinical
communication regarding diagnosis and intervention, the leaflet can be divided into lateral (P1),
central (P2) and medial scallops (P3). The anterior leaflet is trapezoid-shaped and attached to
the fibrous part of the annulus. This leaflet is longer, thicker and larger than the posterior
leaflet, and can similarly be distinguished by lateral (A1), central (A2) and medial scallops
(A3) [11]. The chordae tendineae are string-like structures which attach the ventricular-facing
leaflet surface to the papillary muscles (Figure 1.6). Due to their collagenous structure, the
chords do not stretch beyond 10% in physiologic conditions. The muscular components of the
mitral apparatus are the papillary muscles and left ventricular wall. Two papillary muscles are
positioned along the mid to apical region of the left ventricular wall [28].
Figure 1.6: An unfolded mitral valve depicting the atrial leaflet surface, papillary muscles attached to
the chordae tendineae and the anterior, posterior leaflets and commissures [11]
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Normal function of mitral valve allows unimpeded blood flow into the left ventricle during
diastole, and prevents backflow of blood into the left atrium during systole. The healthy mitral
valve undergoes substantial dynamic changes in both size and shape over the length of the
cardiac cycle. After left ventricular contraction, the aortic valve closes and the mitral valve
opens, allowing blood to flow from the atrium to ventricle. Complete closure (defined as
coaptation) and correct symmetrical overlap of the posterior and anterior leaflets are essential
for normal, non-regurgitant valve function [41]. The mitral valve has a distinctive motion
pattern during the cardiac cycle, which can be correlated to electrical activity tracked by the
ECG wave (Figure 1.7) [71].
The valve remains closed early in diastole, during the isovolumic ventricular relaxation
phase; as the ventricular muscle relaxes in late ventricular diastole, pressure in the chamber
drops below pressure in the atrium and the mitral valve opens to allow blood to flow down its
pressure gradient from the atrium to the ventricle. Ventricular systole follows depolarization
of the myocardial cells in the ventricle wall (the QRS complex on the ECG). Due to specific
innervation, papillary muscles contract before the ventricular wall which keeps the chordae
under tension. With ventricular wall contraction, the pressure in the chamber rises higher
than diastolic atrial pressure [63], causing the mitral valve to close to prevent backflow of
blood to the atrium, in preparation for the ventricular ejection phase at the end of systole.
After valve closure, papillary muscles are stretched during ventricular contraction, facilitating
optimal valve coaptation [26].
1.3 Mitral Valve Disease
Normal mitral valve function relies on a carefully coordinated mechanism and interplay be-
tween the individual components of the valve complex. Both congenital and acquired disor-
ders can impair this mechanism and the result is a regurgitant, diseased or overall incompetent
valve. This section outlines different pathophysiologic variants of mitral valve disease.
1.3.1 Mitral Valve Regurgitation
Mitral valve regurgitation (MVR) is the most common valve dysfunction in US population
[51]. Regurgitant valves have incomplete or insufficient leaflet coaptation. As a result, part
of left ventricular stroke volume flows backwards into the atrium rather than forwards through
aorta during systole. During diastole, when the valve is open, the regurgitant volume is re-
turned to the left ventricle and leads to ventricular volume loading. MVR has a wide range of
causes, including mitral valve prolapse, flail leaflets (Figure 1.8c), damaged or ruptured chor-
Chapter 1. Introduction 9
Figure 1.7: Mitral valve motion correlated to the stages of the ECG wave [71]
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dae, rheumatic fever, endocarditis, congenital heart defects, untreated high blood pressure and
general valve damage due to wear and tear. Symptoms of mitral valve regurgitation include:
heart murmur due to turbulent flow through the heart, shortness of breath (especially during
exertion or lying down), fatigue, lightheadedness and heart palpitations. The severity of MVR
is assessed on a graded scale from mild to severe; individuals can live with functional, mild
MVR without treatment but once classified as severe, a course of intervention is determined
for valve repair or replacement [1].
1.3.2 Mitral Valve Stenosis
Mitral stenosis is the narrowing of the valve opening such that blood flow is obstructed be-
tween the left atrium and ventricle. Typically, mitral stenosis arises with valve scarring from
rheumatic fever, however some individuals can be born with the condition. Unless classified as
severe, mitral stenosis does not present with symptoms. Severe mitral stenosis causes similar
symptoms to mitral valve regurgitation such as shortness of breath, fatigue, dizziness and heart
palpitations [6].
1.3.3 Mitral Valve Prolapse
Mitral valve prolapse (MVP) is characterized by an abnormal protrusion or bulging of parts
of the valve leaflet into the atrium (beyond the plane of the mitral annulus) during ventricu-
lar systole (Figure 1.8b). MVP is the leading cause of mitral regurgitation and is cited as the
most oft-occurring reason for mitral valve surgery, affecting nearly one in 40 individuals [21].
However, MVP has a wide range of presentations and the cause can either be primary or sec-
ondary. Primary MVP includes cases where the main abnormality exists in the mitral leaflet,
while secondary MVP indicates dysfunction in the subvalvular mitral apparatus [5]. Though
mitral valve prolapse is typically a lifelong disorder, the symptoms experienced by individuals
are greatly variable with some never experiencing any signs of prolapse or regurgitation. Any
symptoms that prolapse patients present with are typical of mitral valve regurgitation, initially
with mild severity and developing gradually.
1.3.4 Degenerative Mitral Valve Disease
Degenerative mitral valve disease (MVD) is the most common form of organic mitral valve
disease in developed countries, with incidence in the US estimated to be 2-3% [21]. MVP
is the most common functional abnormality associated with degenerative MVD, as a result
of both leaflet redundancy (from abnormal connective tissue) and chordae elongation (making
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Figure 1.8: Mitral valve in systole for (a) normal case (b) degenerative MVR due to prolapse (c) degen-
erative MVR due to flail leaflet and (d) functional MVR (Image Courtesy of Abbott Vascular)
them prone to rupture). There is high variation in the pathological characteristics of individuals
with degenerative MVD. Severe regurgitation follows rupture of elongated chordae, due to
unsupported and flail leaflets. With increased severity of MVR, so does the risk of heart failure,
atrial fibrillation and death due to cardiovascular complications [20].
1.4 Mitral Valve Imaging
As structural heart disease interventions continue to evolve, accurate and reliable imaging
is necessary for diagnosis, pre-operative selection of cases, intra-operative guidance, post-
operative evaluation and longitudinal follow-up of patients. Though much is known about
mitral valve behavior in healthy and abnormal individuals, a complete understanding of the
complexity of valve anatomy and function remains an active area of research. It is an ongo-
ing challenge to fully capture the dynamic movements and interaction of valvular components
to describe physiology during the cardiac cycle. Medical imaging is the key assessment tool
to non-invasively comprehend details of dynamic mitral valve morphology and disease for
decision-making and treatment planning [20]. For all medical imaging, visualization in 3D is
preferred over 2D as it allows better understanding of the spatial relationships between adjacent
anatomic structures.
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1.4.1 Ultrasound
Due to its ability to capture images in real time, ultrasound is ideally situated to capture the
rapid, dynamic movement of the mitral valve over the length of the cardiac cycle. The mitral
valve is complex, with a unique arrangement of its component parts within the left ventricle.
Cross-sectional imaging techniques including 4D echocardiography allow the valve to be vi-
sualized in its entirety by acquiring a whole series of planes [31]. Echocardiography is the
preferred modality for diagnosing the presence of severity of MVD in addition to assessing the
underlying etiology.
Colour Doppler Imaging
Colour Doppler 3D TEE is a valuable technique, widely used to identify both the location of the
regurgitant orifice and the severity of MVR [73]. With the capabilities of Doppler volumetric
methods, there are several parameters available to determine severity of MVR such as the area
ratio between the regurgitant jet and left atrium, vena contracta width and effective regurgitant
orifice area (Figure 1.9). However, no single parameter can grade the severity of MVR on
its own, and an integrated approach with a combination of volumetric data is necessary for
thorough analysis. Measurements made with Doppler imaging are limited to an estimation of
the MVR, as colour images are easily confounded by variations in patient hemodynamics and
operator-selected gain settings. As such, colour flow imaging is effective for diagnosis of MVR
but should not serve to quantify the regurgitation [25].
Transthoracic Echocardiography
Transthoracic echocardiography (TTE) is the main tool used for an initial assessment of mitral
valve pathology in daily cardiology practice [55]. TTE images are acquired by sliding, rotating
and tilting an ultrasound transducer on the gel-covered surface of the chest. First, a parasternal
long axis view is acquired to assess the leaflet thickness and evaluate their motion during the
cardiac cycle. Next, a short axis parasternal view captures the attachment of leaflets to the
chordae, and mitral valve area can be measured. Finally, apical four chamber and long axis
views are acquired to visualize leaflet coaptation and estimate the degree of possible regurgi-
tation with Doppler. While TTE is sufficient and oft-employed for initial valve imaging, when
visualizing the mitral valve, TTE is limited by the structures surrounding the heart, such as the
lungs and ribs. Since these images are acquired superficially, the ultrasound waves are often
obstructed by these areas before reaching and providing a clear picture of the valve.
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Figure 1.9: Diagnostic, preoperative TEE images of the mitral valve (left) and color Doppler image
(right) depicting mild to moderate functional MVR [47]
Transesophageal Echocardiography
While TTE is the primary modality for diagnosis and evaluation of MVD, transesophageal
echocardiography (TEE) is an important adjunct for patients in need of more detailed visu-
alization of left atrium and valve morphology. Due to the proximity of the esophagus to the
upper chambers of the heart, acquisition with a TEE probe can provide very clear and detailed
images of different cardiac structures and valves. TEE has become an invaluable diagnostic
tool, detailing the underlying anatomical mechanism for clinician preparation prior to a surgi-
cal or percutaneous repair. The first use of 2D TEE during cardiac surgery was in 1979, which
promoted the development of 3D TEE to reduce the cognitive load on clinicians. Further, 3D
echocardiography moves beyond the 2D cross-sectional heart views to anatomic images that
correspond to a Cartesian coordinate system [64]. 3D TEE is also used intro-operatively to
guide percutaneous procedures for valve repair, as well as post-operatively to assess outcomes
of valve surgery. Images are acquired from an ultrasound probe inserted into a patient’s esoph-
agus in some cases while they are under a local anesthetic. Along with progression down the
length of the esophagus, the probe head can be rotated and tilted to different angles and provide
a range of cardiac views.
There are three prerequisites for optimal 3D TEE acquisition of dynamic MV morphology:
(1) high temporal resolution for a frame-by-frame analysis of leaflets (2) high spatial reso-
lution to visualize and classify fine morphological details 3) large volumetric dataset which
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Figure 1.10: Stylized depiction of TEE probe in the mid-esophagus and the subsequent short axis, four
chamber view (Image Courtesy of Toronto General Hospital Department of Anesthesia)
captures MV from commissure to commissure [73] (Figure 1.10). However, in real-time 3D
TEE imaging there is a tradeoff between temporal resolution (frame or volume rate) and size
(width and depth) of the data set. In comparison to TTE, TEE imaging is superior for diagno-
sis of infective endocarditis. Drawbacks of using TEE for imaging the mitral valve include its
invasiveness and the spatial constraints of the esophagus. These confines necessitate small and
subtle probe motions to obtain adequate imaging windows. As well, TEE is resource intensive,
often uncomfortable for patients and associated with complication risks [3]. Both temporal
and spatial resolutions impact the image quality of 3D TEE, as well as the cognitive limita-
tions of comprehending the 3D echo images displayed on a 2D screen (with colour used to
demonstrate depth and reality). As with other 3D imaging modalities, 3D TEE is impacted
by artifacts such as stitching artifacts, dropout (dropout artifacts can mimic valvular perfora-
tions and periprosthetic leaks [59]), blurring or thickening of structures. The evaluation of
the submitral apparatus is challenging from the conventional TEE approach [54]. The con-
ventional mid-esophageal approach at the mitral valve level allows for clear visualization of
the mitral annulus and leaflets (as the ultrasound beam is nearly perpendicular to the annular
plane). However, in this orientation the beam is parallel to the chordae and the long axis of the
papillary muscles and therefore any imaging of the subvalvular apparatus is sub-optimal [27].
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Figure 1.11: (a) 3D TEE image of mitral valve in mid-diastole from overhead (surgeon’s) perspective;
three scallops of posterior leaflet, inter-scallop indentations/minor commissures (arrows), 3 divisions
of anterior leaflet; asterisks point to two commissures and (b) 3D TEE image of closed mitral valve in
systole with three scallops of posterior leaflet labelled [73]
Transgastric Echocardiography
Transgastric echocardiography is an extension of TEE; the transgastric views are acquired
when the TEE probe is progressed along the length of the esophagus and into the stomach
(Figure 1.12). These images provide optimal evaluation of the left and right ventricular func-
tion through ejection fraction calculation and post-operative wall motion assessment. As well,
deep transgastric views (with the probe inserted far into the patients stomach) can assess the
degree of aortic stenosis or regurgitation. It is relatively unknown how effective transgastric
echocardiography would be for imaging the mitral valve; since image acquisition is highly
operator-dependent, the experience and technique of the clinician maneuvering the TEE probe
will significantly impact which structures are visualized by the transgastric view. However, a
recent study demonstrated that visualization of the submitral apparatus using transgastric 3D
TEE imaging was both feasible and enabled accurate measurements of primary chords [54]. In
the transgastric position, the ultrasound probe is mostly perpendicular to chords and papillary
muscles, enabling a clearer view of submitral apparatus. Drawbacks of transgastric echocardio-
graphy imaging are that acquisition is extremely operator-dependent, resulting scans are still
subject to relatively poor image quality and often depict ambiguous structures. Post-processing
work done to improve transgastric echo images is time-intensive with highly variable outcomes.
Chapter 1. Introduction 16
Figure 1.12: Stylized depiction of TEE probe in the transgastric position and the subsequent long axis,
four chamber view (Image Courtesy of Toronto General Hospital Department of Anesthesia))
1.4.2 Computed Tomography
Computed Tomography (CT) is an increasingly important adjunct to echocardiography for the
evaluation of MV disease and regurgitation [48]. CT has an important role in identification
of acquired or congenital conditions with resultant regurgitation or stenosis. Additionally,
CT is used to detect and monitor postoperative complications after mitral valve repair and
replacement procedures.
The main application of cardiac CT is in angiography studies, which involves injection of
a contrast medium and acquisition is structured to allow for assessment of the coronary ar-
teries along with valvular structure and function. These scans are typically performed on a
multidetector scanner with a minimum 64-row capacity with retrospective ECG gating. For
patients with functional MVR, multidetector row CT can detect the presence of leaflet remod-
elling [37].The benefits of cardiac CT include total visualization of cardiac anatomic features,
including coronary arteries, paravalvular structures and cardiac wall motion [35]. As with
other applications of CT, the radiation dose is modulated in accordance with the ”as low as
reasonably achievable” principle.
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Figure 1.13: Cardiac low dose coronary artery map derived from a surface reconstruction from a 3D
acquisition using the GE Revolution CT Scanner (GE Medical Systems, Waukesha, WI)
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ECG Gating
The main challenge with cardiac CT is temporal resolution. Image acquisition follows rota-
tion of the gantry (containing both the xray source and detector), and this must occur faster
than cardiac movement during contraction to avoid image blurring. In addition, the acquired
images capture distinct events occurring over the cardiac cycle, and there must be synchrony
between the acquired data and the ECG waveform. Two methods (prospective and retrospec-
tive ECG gating) can be used to accomplish this phase-matching. For prospective ECG gating
or triggering, the patient’s ECG is monitored and the scanner only acquires images during car-
diac diastole (typically, the heart has minimal motion during ventricular filling) (Figure 1.13).
The scanner interprets a delay after the QRS complex and then triggers the “step and shoot”
technique, repeating this for subsequent cardiac cycles until the entire heart has been covered.
In contrast, retrospective ECG gating acquires images continually throughout the cardiac cy-
cle, and selectively reconstructs image volumes from a desired phase after the entire scan is
completed (Figure 1.14). Since the scan acquires images at all phases of the cardiac cycle,
it is possible to reconstruct images in systole, diastole or any point between the two stages
[62]. Considerations for which method to use include desired temporal resolution, temporal
flexibility, radiation dose and ECG dose modulation.
Figure 1.14: Prospective Gating for Cardiac CT (Image Courtesy of XRay Physics)
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Figure 1.15: Retrospective Gating for Cardiac CT (Image Courtesy of XRay Physics)
CT Image Artifacts
Artifacts are often encountered in both clinical and research applications of computed tomog-
raphy. These artifacts corrupt the resulting images as they can obscure or simulate pathology.
Common CT imaging artifacts include noise, beam hardening, scatter, motion, cone beam, hli-
cal, ring and metal artifacts. Techniques have been developed to reduce artifacts, such as iter-
ative reconstruction or combining data from multiple scans. These methods are advantageous,
as they enable lower radiation dose for the patient, higher resolution scans and more accurate
diagnoses. Dual and multi-energy CT can reduce beam hardening artifacts and enhance tissue
contrast [8].
Image artifacts relevant to this thesis are those most prevalent in 4D-CT images. These
are due primarily to cardiac and respiratory motion. There are generally four types of artifacts
which impact 4D-CT image acquisition: (1) blurring, (2) duplicate structure, (3) overlapping
structure, and (4) incomplete structure. Blurring artifacts result from organs moving faster than
the CT gantry rotation speed. Duplicate, overlapping and incomplete structure artifacts occur
at the interface between two adjacent slices, and result in images with omitted, distorted or
simulated underlying tissue [70].
4D Dynamic Computed Tomography (4DCT)
Dynamic, 4D-Computed Tomography is an exciting, relatively new imaging modality which
is used primarily for perfusion studies to visualize blood flow and overall cardiac movement
(Figure 1.15). It is relatively unknown how dynamic CT would perform for valve imaging,
but it has the potential to provide both a high quality rendering of the valve and subvalvular
apparatus and reliable volumetric data. However, there are challenges to imaging valve motion
with CT. First, the CT gantry must rotate faster than the valve moves during the cardiac cycle.
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Figure 1.16: GE Revolution CT Scanner for acquisition of dynamic, 4D-CT images (GE Medical Sys-
tems, Waukesha, WI)
Valve motion becomes more rapid at higher heart rates, typical of regurgitation patients and the
period between diastole and systole shortens. Determining the ability and accuracy of 4DCT
for mitral valve imaging is one of two main objectives of this thesis.
1.4.3 Magnetic Resonance Imaging
Cardiac Magnetic Resonance Imaging (MRI) provides the gold standard of visualizing gross
cardiac function and anatomy. MRI is based on the magnetization properties of nuclei in com-
mon atoms throughout the body; patients are scanned within a powerful, uniform, external
magnetic field used to align protons within water molecules in vivo within the tissue under ex-
amination. Depending on the type of subsequent external RF pulse sequence, different types of
images are created of patient anatomy. Cardiac MRI typically involves ECG gating and breath-
hold acquisitions. For mitral valve imaging, balanced steady-state free precession (SSFP) se-
quences applied in the short-axis plane of the heart [48] produces morphologic evaluation of the
mitral valve and identification of jets indicative of regurgitation or stenosis (Figure 1.16). Since
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Figure 1.17: Cardiac MRI image depicting the left atrium, left ventricle, aorta, mitral valve and aortic
valve (Courtesy of Center for Medical Imaging and Physiology, Department of Clinical Physiology at
Lund University)
the size and length of the jet visible in SSFP images depends on a large number of factors, these
morphological characteristics cannot estimate the severity of mitral valve dysfunction. Cardiac
MRI is ideally suited for providing accurate, noninvasive quantification of mitral regurgitation
1.5 Mitral Valve Image Processing
Image processing describes different methods used to perform operations in order to extract
useful information or enhance an image, and is analogous to signal processing, where the in-
put is an image and the output can be an image or different features associated with the image.
Medical image processing applies these techniques to medical images derived for both diagnos-
tic and therapeutic purposes, encapsulating the analysis, enhancement and display of images
acquired with x-rays, ultrasound, MRI, nuclear medicine and optimal imaging modalities.
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1.5.1 Segmentation
Medical image segmentation extracts a region of interest (ROI) either by an automatic or semi-
automatic process. Often, the ROI is a particular tissue or organ. For patients with MVD,
the ROI is often the valve complex, segmented from a 3D TEE image. Thresholding is based
on the assumption that images are divided into regions of different grey level, and is one of
the quickest and easiest methods for segmentation. The corresponding histogram has varying
peaks and valleys which serve to divide the image into different sections, often background
and area of interest. Region growing is an interactive segmentation method which requires
initialization by user-selected seed points to begin the process. With this technique, regions
are grown around the user-defined seed point based on areas of intensity homogeneity. Other
methods employ boundaries such as active contours and graph cuts to delineate the region of
interest.
1.5.2 Registration
Image registration involves the alignment of two or more images into a common spatial re-
gion. The goal of image registration is to find the optimal transform which best aligns the
regions of interest in the two input images. Applications of medical image registration include
overlapping images of the same patient from different modalities, aligning temporal sequences
of images to compensate for motion artifact between scans and image-guided interventions.
Current algorithms can automatically register images that are related by a rigid body trans-
formation, such that tissue deformation is negligible. As well, non-rigid or deformable regis-
tration algorithms can compensate for tissue deformation. Methods such as landmark-based,
homologous-point registration and Normalized Cross Correlation (NCC) are used in this thesis.
1.6 Mitral Valve Interventions
In accordance with current guidelines, patients with symptomatic organic MVR along with
asymptomatic patients with left ventricular dysfunction, significant pulmonary hypertension
and atrial fibrillation are advised and referred for surgery [67].
1.6.1 Mitral Valve Repair
Mitral valve repair is widely accepted as the preferred and optimal surgical intervention of
valve dysfunction and disease [45]. Supporting evidence for regurgitation due to degenerative
mitral valve disease strongly favours repair over replacement. A successful repair is based
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on proper understanding of the anatomic and functional changes of the diseased valve, clas-
sified by Carpentiers analysis of leaflet motion [9]. The main goal of repair surgery is to
preserve as much of the native valve tissue and subvalvular apparatus as possible. This in-
volves patching holes in and rebuilding the valve, reconnecting leaflets, removing excess tissue
to increase leaflet coaptation, replacing cords and separating fused leaflets. Another example is
mitral valve annuloplasty, an oft-employed surgical technique used to repair a regurgitant valve
through implantation of an annuloplasty ring device. These devices are designed to increase
leaflet coaptation while preserving the native valves annular shape and motion [57].
The advantages of valve repair include lower operative mortality, better preservation of left
ventricular function and improved valve durability post-repair. A majority of surgeons have
adopted mitral valve repair as the method of choice for correction of MVR. For patients with
the most common form of isolated prolapse of the middle scallop and posterior leaflet, success
rates for repair surgery are nearly 100% [14]. The main advantage of repair is freedom for
patients from the side-effects to the alternative replacement procedure; annuloplasty does not
require lifelong anticoagulation, and there are no thromboembolic complications which can
occur with valve replacements. However, there are limitations of the repair procedure, and the
feasibility of repair depends both on patient pathology and the experience of the clinical team.
In particular for patients with secondary severe MVR and a low ventricular ejection fraction. In
such cases, eliminating the regurgitation increases the left ventricular afterload and may induce
post-operative low cardiac output syndrome [61].
Traditionally, mitral valve repair has been performed with invasive, open-heart surgery
where the patient is connected to the heart-lung bypass machine. However, recent develop-
ments in biomedical engineering and robotics have employed image-guided tools to enable
minimally-invasive, beating-heart mitral valve repair [13]. This reduces the overall impact
on patients, surgical risk and recovery times that are a side-effect with open heart surgery.
These minimally-invasive approaches rely on the insertion of catheters through a small inci-
sion into particular arteries and veins in the body in order to access the heart and its valves.
One commonly-accessed entry point is the femoral vein, through which a catheter can be pro-
gressed to the inferior vena cava and into the right atrium. Percutaneous transcatheter mitral
valve repair with a MitraClip device has resulted in good outcomes for patients with primary
regurgitation and high surgical risk [50]. For this procedure, the catheter is used to puncture
the septal wall (separating the right and left atria) to cross into the left side of the heart, access
the mitral valve and deploy a clip(s) to hold the two leaflets of a regurgitant valve together
for improved closure during systole [30]. An analogous, minimally-invasive procedure used to
treat aortic valve stenosis in transcatheter aortic valve implantation (TAVI); guided through a
small incision in the groin or chest, a catheter deploys and implants a new aortic valve on top
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of the stenotic tissue.
1.6.2 Mitral Valve Replacement
In the event that the patients native valve cannot be repaired, clinicians may recommend mitral
valve replacement. There are various options for valve replacements, including replacing the
native valve with either a mechanical (titanium and carbon) or bioprosthetic (bovine, porcine
or human heart tissue) valve. Among consideration for valve selection is patient age since
bioprosthetic valves have a shorter lifespan and will need to be replaced in 10 years, so they are
typically acceptable for patients greater than 60 years of age. The tradeoff with the mechanical
valve is that the patient will require blood-thinning medications for the remainder of their
life to prevent clots; however, when replacement is the only option for restoring mitral valve
function, a mechanical replacement is most suitable for younger patients. Whenever possible
with replacement surgery, chords are preserved and attached to the new mitral valve. There
is evidence that preservation of chordae and papillary muscles during replacement for chronic
MVR is beneficial for postoperative left ventricular function [50]. Prosthetic valve-related
complications include thromboembolism, anticoagulant-related hemorrhage and endocarditis.
1.7 Patient-Specific Mitral Valve Models
Surgical simulation involves imitation of an operation on cadavers, animals, models or simu-
lators in order to teach and train a clinicians skills, decision-making and exposure to complex
cases. In cardiac surgery, personalized analytical heart models have become a crucial compo-
nent of the clinical workflow, especially with complex disorders such as valvular heart disease
[39]. As technology has developed to facilitate minimally-invasive procedures, clinicians must
also acquire and practice new skill sets for navigating tools and interpreting patient anatomy
with image guidance. Image-guided procedures enable beating-heart surgery, but pose new
challenges and risks by removing the clinicians direct line of sight [46]. The success of these
interventions relies on patient-specific simulators for pre-operative planning: this includes at-
tempting different access routes, deploying sutures and analyzing their accuracy, navigating
variations in patient anatomy and repeating the procedure under image-guidance so as to re-
duce the cognitive load when performing the actual operation. As a way of expanding beyond
the “see one, do one, teach one” concept for surgical training [36], simulators and patient-
specific models can provide a realistic environment which is compatible with various imaging
modalities. Patient-specific modelling allows clinicians to gain insight into uniquely intricate
anatomy prior to a medical intervention.
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Figure 1.18: Workflow for creation of pre-operative, patient-specific mitral valve models
It is widely accepted that the mitral valve has a highly complex and variant dynamic struc-
ture with a direct impact on the hemodynamic changes following left ventricular contraction
during the cardiac cycle [52]. Dynamic valve models can simulate the morphology and func-
tion of a diseased, regurgitant valve such that clinicians can interact with and practice different
repair or replacement techniques prior to the actual surgery. The workflow for creation of these
patient-specific mitral valve models is depicted in Figure 12. The mitral valve is segmented
from a patients diagnostic TEE and rendered as a volume for rapid prototyping into a silicone,
tissue-mimicking valve [24]. Next, the valve is inserted into a dynamic left ventricular phantom
with blood-mimicking fluid which provides realistic, apical-to-basal motion patterns at varying
heart rates. This phantom can be used to simulate valvular repair and replacement procedures
with magnetic tracking, augmented reality, fluoroscopy and ultrasound guidance [69]. Cur-
rently, echocardiographic-based mitral valve models are in the early clinical validation phase.
In addition to providing a realistic training and pre-operative planning environment for
clinicians, surgical simulators also act as a platform for validating new image-guided, virtual
and augmented reality techniques. To ensure these systems provide accurate tracking, image
information and will reduce the cognitive load during surgery, they are validated and tested
using physiologically-relevant models [38], [44], [43]. Surgical phantoms with generalized or
patient-specific anatomy allow for simulation of a specific procedure. Throughout the litera-
ture, there is evidence that incorporating surgical simulators and patient-specific models into
the education and training of clinicians can reduce negative outcomes for patients [42], [4].
1.8 Clinical Challenges with TEE
Reliance on imaging for diagnosis and intervention of mitral valve disease introduces a host
of challenges to the clinical team. Images will be impacted by the quality, age and calibra-
tion of the scanner. By depending on imaging modalities for comprehensive information of
patient structure and pathology, clinicians can make decisions regarding the tools and devices
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Figure 1.19: Effects of signal dropout in patient TEE images on valve segmentation
best suited to intervention; in many cases, preoperative imaging provides sufficient informa-
tion to allow clinicians to make informed decisions and perform the procedure with confidence.
However, there are the cases where a patient has complex anatomy, or the cause of regurgita-
tion remains unclear without an understanding of subvalvular structures. Additional imaging
may be needed, though the clinician can still be left without a complete understanding of the
best course of action for intervention. For complex, atypical cases and patients undergoing
minimally-invasive, beating-heart mitral valve repair or replacement, patient-specific models
and simulators are a useful preoperative planning tool. Currently, the development of these
models is limited by the quality of the patient images from which they are derived.
Multiple pervading issues with TEE images impair diagnosis of regurgitation in the clinical
workflow and challenge the implementation of the patient-specific modelling pipeline. The first
is the prevalence of signal dropout, appearing as gaps within the valve leaflet in regions that
should present as contiguous tissue (Figure 1.19).
For diagnosis, images affected by dropout make it difficult for clinicians to determine the
cause of regurgitation; for modelling, the valve cannot be completely segmented and the result-
ing models have holes (Figure 1.20). Thus, there is a loss of some patient-specific morphology
and the efficacy of the models is decreased. The second issue is the presence of additional im-
age artifact which appear as high intensity regions in the TEE images and can be misconstrued
as leaflets or other anatomical structures (Figure 1.21).
Similarly, regions of artifacts affect the diagnostic value of the TEE and pose challenges to
the modeling process. In addition, the TEE images provide a limited view of the valve, without
any indication of the structure or function of the subvalvular anatomy. Often, the source of
regurgitation is indeterminable due to the absence of information on the annulus, chordae and
papillary muscles. In addition, there is evidence that intra-operative use of TEE for mitral valve
repair has resulted in a rate of recurrent regurgitation of 5% after 1 month and 40% after 4 years
[19]. Steps towards both improving and augmenting TEE applications in mitral valve imaging
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Figure 1.20: Volume rendering of TEE segmentation with holes due to regions of signal dropout
Figure 1.21: Intensity artifact in TEE image often misconstrued as valve tissue
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will be beneficial for diagnosis, modelling and pre-, intra- and post-operative evaluation of
valve function.
1.9 Summary
Given the high, interpersonal variability of mitral valve tissue, patients affected with MVD
and subsequent regurgitation each have a unique path from diagnosis to intervention and re-
covery. Decisions in mitral valve disease management rely heavily on non-invasive imag-
ing. Echocardiography, specifically acquired with a transesophageal probe, is considered the
standard-of-care for diagnosis, intervention planning and guidance, and post-operative assess-
ment. In most cases, TEE imaging is sufficient for identifying pathology and underlying causes
of regurgitation. However, due to limitations such as signal dropout, artifacts, limited resolu-
tion and operator-dependence for image interpretation, the diagnostic value of TEE is often
impacted. As well, due to the high volume of elderly patients unable to undergo invasive, open
heart surgery for valve repair or replacement, new tools and techniques have been developed
for image-guided, beating-heart approaches. For these new procedures, patient-specific mod-
els have an essential role in training clinicians and validating new devices for guidance and
surgery. These models rely on segmentation of the mitral valve from a TEE, which has its
own set of challenges. It remains unknown whether intensity-based segmentation methods are
accurately and reliably delineating the mitral valve complex from TEE images.
Due to advancements and recent developments in imaging modalities, there is an increasing
ability for clinicians to acquire a complete understanding of their patients intricate, dynamic
anatomy. Dynamic computed tomography (4D-CT) is emerging as a valuable tool for both di-
agnosis and assessment of cardiac diseases. However, it is virtually unknown how this modality
would perform for mitral valve imaging. Before initiating animal or patient studies, a proof-of-
concept phantom study is needed to identify and quantify the abilities of the 4D-CT for mitral
valve imaging.
With the widespread use of relatively inexpensive rapid prototyping techniques, simulators
modelled off of patient anatomy are widely available. For minimally-invasive cardiac surgery,
this application of modelling is particularly important, as clinicians are required to operate
on a beating heart, without a direct line of sight into the area of interest. As well, for valve
repair and replacement procedures, pathologic patient anatomy is highly variable as no two
valves function or fail by the same mechanism. With mechanically-controlled motion and
deformations, physical cardiac phantoms provide a platform for developing image-guidance
and image-processing techniques. The first step to any patient-specific modelling pipeline
is segmentation of diagnostic imaging, and in the case of mitral valve disease, segmenting
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a patients TEE. Segmentation is also used for pre-operative quantitative analysis to inform
subsequent interventions and treatment. However, intensity-based segmentation methods of the
mitral valve from TEE images must be validated and assessed for their accuracy to delineate
valve leaflets, used to create simulators.
The potential benefits and challenges of dynamic, 4D-CT for mitral valve imaging are the
motivations for this work. We investigate and evaluate how reliably dynamic CT captures the
morphology and behavior of the mitral valve in a beating heart. As well, we explore how mitral
valve movement in dynamic CT might degrade image quality or introduce artifacts. Finally,
we use a dynamically-acquired set of CT images from both silicone and bovine phantoms as
ground truth in a comparative study with simultaneous TEE imaging.
1.10 Objective 1
1.10.1 How accurately does dynamic CT capture mitral valve
morphology and dynamics?
At the outset of this research, it was largely unknown how dynamic, 4D-CT of the mitral valve
with the GE Revolution scanner would capture valve morphology and function. With evidence
of limitations of TEE for diagnosis, intra-operative guidance and patient-specific modelling
of complex MVD cases, the first objective of this thesis was to evaluate 4D-CT capability of
imaging the valve complex under physiologic conditions. To address this, we created a quasi-
static phantom with both silicone and bovine valves to mimic normal valve motion patterns and
be arrested at precise cardiac phases. The methodology and results of this proof-of-concept,
phantom study are presented in Chapter 2.
1.11 Objective 2
1.11.1 How accurately does transesophageal echocardiography identify
the mitral valve?
With the phantom construction and results from Chapter 2, the focus of validation could return
to the realm of TEE and patient-specific modelling. The second objective of this thesis was
to use both statically- and dynamically-acquired images of silicone and iodine-stained bovine
mitral valve phantoms to serve as ground truth for comparison to simultaneously-acquired TEE
images. The motivations for this project are the limitations and ambiguity of TEE mitral valve
segmentation, which has an important role in quantitative assessment of valve function pre- and
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post-operatively as well as in patient-specific modelling. Our primary goal was to demonstrate
how accurately and reliably an intensity-based segmentation of a mitral valve from a TEE
image actually delineates the valve complex. The results and statistical analysis from these
experiments are reported in Chapter 3.
1.12 Thesis Outline
The chapters are as follows:
• Chapter 2 develops the construction of a quasi-static, silicone and bovine valve phantom
for construction of a ground truth dataset to validate 4D dynamic CT with mitral valve
imaging.
• Chapter 3 presents the results from a study using a CT ground truth dataset to validate
TEE for mitral valve imaging and segmentation, as used in patient-specific models.
• Chapter 4 provides a detailed discussion of the work from Chapters 2 and 3 in addition
to outlining the future directions of this research.
Each chapter is prefaced with an additional introduction illustrating recent work similar to the
topic at hand.
Chapter 2
Accuracy of mitral valve imaging in
dynamic 4D-CT
This chapter is largely based on the podium presentation:
• “Accuracy of mitral valve imaging in dynamic CT” in the session on Advanced Imaging
for the Heart and Heart Valves at Computer Assisted Radiology and Surgery (CARS),
June 2018 in Berlin, Germany
2.1 Introduction
With the significant increase in life expectancy over the past century, valvular heart disease
(VHD) has been identified as the next cardiac epidemic. A recent study estimates that preva-
lence of VHD to be 2.5%, progressively increasing with age up to 13.2% at 75 years of age
[5]. Transesophageal echocardiography is widely recognized as the standard of care evalua-
tion technique to diagnose mitral valve diseae. In most cases, TEE imaging is adequate for
identifying pathology, however due to limitations such as signal dropout, limited resolution
and user-variability in interpreting images, the diagnostic value of TEE is often limited. TEE
images are unable to capture subvalvular anatomy and for some patients, the cause of regurgi-
tation is ambiguous and remains unknown. As a result, pre-operative planning is limited and
the surgical outcome is affected. For inter-operative TEE-guidance with mitral valve repair, the
modality is often unable to provide a comprehensive view of the underlying valve disfunction,
such that there are nontrivial rates of post-operative, reccurent regurgitation [4]. Conversely,
the use of dynamic 4D-CT to capture a complete picture of the valve and subvalvular appa-
ratus could enable surgeons to personalize their approach to intervention and reduce the rate
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of recurring MVR. In addition, the emerging availability of beating-heart valve replacements
necessitates pre-operative stent sizing. TEE cannot provide accuate volumetric data which is
used to pre-operatively size neochordae and valve stents for beating heart replacements. As
well, post-processing of TEE images for further analysis or patient-specific modelling is lim-
ited by signal dropout, artifacts and ambiguity of high-intensity regions. These factors motivate
the use of 4D-CT to augment TEE in the clinical workup of MVD for quantification of patient
anatomy. Dynamic cardiac computed tomography is emerging as a valuable tool for diagnosis
and assessment of cardiac disease. However, application of dynamic CT to mitral valve imag-
ing is particularly challenging due to the large and rapid motion of the mitral valve leaflets.
Therefore, it is important to investigate the level of precision with which dynamic CT captures
mitral valve morphology throughout the cardiac cycle. CT has the potential to provide a high
quality rendering of the mitral valve apparatus and subvalvular anatomy, which is lacking in
other cardiac imaging modalities. In this work, we propose a method to assess the accuracy
of dynamic CT imaging of the mitral valave, validated through comparison with a static but
adjustable ground truth phantom. Outcomes of this study will assist in evaluating the potential
of dynamic CT as an effective tool in mitral valve applications. The results from this work
can inform the use of dynamic CT in the clinical workflow for diagnosis and intervention of
patients with mitral valve disease–, as well as assess the efficacy of transesophageal ultrasound
for accurately capturing valve morphology and dynamic motion.
The main objective of this chapter is to take the initial steps to evaluate the reliability of dy-
namic CT for imaging the mitral valve under laboratory conditions in a custom-made, beating
mitral valve model as well as a bovine valve. To achieve this objective, we evaluate dynamic
CT against static CT that was treated as ground truth. To design the study, we first developed
the phantom and methodology of acquiring synchronized data with static and dynamic CT to
perform a quantitative analysis based on acquired volumetric data and a qualitative assessment
of motion artifacts introduced in the dynamic scan.
2.2 Methods
2.2.1 Overview
The morphology and behavior of the mitral valve is dependent on hemodynamics, which can-
not easily be replicated in a static environment. To address this, we designed and constructed
a quasi-static valvular model, which mimics normal mitral valve morphology and motion
patterns, but can be arrested at precise cardiac phases. This motorized phantom simulated
valve movements over one complete cardiac cycle, from systole to systole. Valve motion was
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achieved by cyclical adjustment of the chordae tendinae, operated by two Arduino-controlled
servomotors. To assess the accuracy of gated, dynamically-acquired mitral valve images, we
arrested the quasi-static valve model at distinct points in the cardic cycle which we compared
with phase-matched, dynamic images. CT images of the silicone valve were acquired in air,
both with the valve in motion and at predefined static positions. CT images of the bovine valve
were acquired in water.
2.2.2 Phantom Design and Construction
Physical Design
After many iterations of modulating the physical design, an orientation was selected which
both optimized the physiologically-accurate valve motion pattern and enabled the system to be
imaged in water with both CT and ultrasound for the validation study in Chapter 3. The final
design consisted of a translucent, plastic container with physical dimensions 21 x 16 x 12 cm,
volume of 3L and wall thickness of 1cm. All electronics were mounted either outside of, or atop
the walls of the container in order to avoid contact with water during the simultaneous CT-TEE
validation study (Chapter 3). A custom-designed valve stand with six screw holes (tapped dur-
ing post-processing) was modelled in SpaceClaim (http://www.spaceclaim.com/en/default.aspx)
to fit the dimensions of a mitral valve annulus, and at an angle that mimics a patient lying
supine. The Stereolithography (STL), Computer-Aided Design (CAD) file for the valve stand
was converted to G-code with Ultimaker’s software Cura 3.3 (https://ultimaker.com/) and 3D-
printed with polylactic acid (PLA) on an Ultimaker 3 Extended 3D-printer. After construc-
tion, the stand was cemented to the base of the container in a location which allowed TEE
probe access from the esophageal side of the valve. A flange made of Smooth-on Dragon
SkinTM silicone (https://www.smooth-on.com/product-line/dragon-skin/) cured into a custom-
made, 3D-printed circular mold with six screw holes, a diameter of 11cm and thickness of
2mm was prepared to support the valve phantoms (silicone and bovine, whose preparation is
described in subsequent sections). The flange was fitted on the valve stand and the holes in
the silicone aligned to the stand screw holes. A ring-shaped, 3D-printed component with an
outer diameter of 11 cm, inner diameter of 5.5 cm and thickness of 0.5 cm and six evenly-
spaced, tapped screw holes (for 10-24 1/2” screws) was constructed to secure and immobilize
the silicone flange and valve phantom to the 3D-printed stand (Figure 2.1, purple compo-
nent). Strategically-placed along the top of the container walls were four customized (mod-
elled in SpaceClaim), 3D-printed cylindrical pulleys which rotate around the centroidal axis.
Two servomotors (HiTEC, https://www.hitecrcd.com, HS-625MG) were screwed into custom-
designed (SpaceClaim) holders and attached to atop the walls on either side of the container.
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These were deliberately placed behind the valve (with no parts of the motor overlaping the field
of view for imaging studies) in order to avoid streaking artifacts from CT of metal components,
which corrupted images acquired with previous phantom prototypes. The output shafts of both
servomotors were fitted with custom-designed (SpaceClaim), 3D-printed lever arm which ex-
tends 3cm outwards from the center of the rotating servomotor shaft. A 2cm long, 1/4” screw
was threaded vertically into the far end of the lever arm, making a radial sweep from 0◦ to 180◦
when the servomotor is operated.
Silicone Mitral Valve Phantom Preparation
Two types of dynamic mitral valve phantoms were designed in our study. The first was a proof-
of-concept, Dragon SkinTM silicone valve which was constructed following the patient-specific
valve modelling workflow outlined in Chapter 1, Figure 1.18. Attenuation and speed of sound
concerns usually make silicone a sub-optimal media for ultrasound phantoms. However, the
anatomical structure of interest in this phantom (the mitral valve) is rarely more than 2mm
thick, which greatly minimizes the adverse effects of attenuation and speed of sound discrep-
ancies between the ultrasound probe and simulated tissue. First, images were acquired from a
diagnostic, dynamic 3D TEE of a patient with mitral valve regurgitation. Next, the mitral valve
was segmented with both automatic and manual techniques from the valve position during di-
astole (ventricular filling, leaflets are open), since the two leaflets cannot be distinguished from
the systolic view of the valve with TEE. A volume rendering was completed in SpaceClaim
to generate a CAD model of the valve. From there, the CAD model was converted to G-code
using Cura software and the positive valve mold was 3D-printed with PLA filament using the
Ultimaker 3 Extended 3D printer. Chords were prepared by taking four thin strings, and fraying
the ends that would rest against the silicone leaflet. To construct the valve, we mixed Smooth-
on Dragon SkinTM silicone, known for its strength and stiffness which is advantageous for the
design constraint of the valve phantom being arrested and immobilized at a specific, repeatable
position for static ground truth creation. We placed the patient-specific, 3D-printed positive
mold inside the circular flange mold and poured the silicone. We then positioned the frayed
ends of the string-chords along the 3D-printed mold of the leaflets and painted silicone with
a brush overtop of the strings to cover the leafelts. Next, the silicone-filled flange and valve
mold apparatus was inserted into a rotating curing device consisting of an Arduino-controlled
servomotor which ensured evenly spread silicone throughout the mold [24]. Once cured, the
silicone flange was screwed onto the stand (as outlined in the previous section). The string-
chordae cured within the silicone leaflets were positioned around the pulleys and secured to
the screw on the lever arm attached to the rotating shaft of the servomotors. The Arduino-
controlled servomotor-and-pulley system adujsted the chordae and which precisely controlled
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their position to simulate a realistic systolic-to-diastolic valve motion pattern over a range of
heart rates (details provided in the next subsection). The silicone valve phantom (Figure 2.1)
has the advantage of an indefinite shelf life, and excellent CT image quality.
Figure 2.1: Silicone valve closed at peak systole and flange secured in 3D-printed stand mimicking
patient lying supine with chords connected to pulleys and servomotors in the Arduino-controlled mo-
torized valve manipulator. Servomotors both at 0◦ angle position.
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Bovine Valve Phantom Preparation
For more realistic valvular anatomy, we performed experiments with a bovine valve. To pre-
pare this phantom, we assembled and replicated the physical design previously described for
the silicone valve phantom. We acquired another container which could accomodate the mod-
ular pulleys and servomotor stand attachments since the dimensions were identical. Next, we
created a second Dragon Flex silicone flange (using the same 3D-printed mold as the flange
for the silicone valve phantom), adding a layer of mesh to the mold before pouring silicone
in order to facilitate sutures of the bovine valve. An entire bovine heart was procured from a
local abbatoir and dissected down to preserve the mitral valve leaflets, chordae and papillary
muscles. Next, the bovine valve annulus was sutured to the silicone flange. Any silicone which
was cured over the region of the leaflets was cut away. Strings (identical to the strings used as
chordae in the silicone valve model) were then sutured into the papillary muscles. This enabled
the bovine valve phantom to be inserted into and actuated by the Arduino-controlled motorized
valve manipulator (described in the next subsection). One week before the date of the imaging
study, a Lugol’s iodine stock solution was prepared. For ten hours prior to scanning, the sutured
bovine valve was immersed in a diluted volume of this stock solution to increase tissue contrast
in CT, following a protocol for iodine-staining of biological tissue for CT imaging [16]. The
workflow for bovine valve preparation is presented in Figure 2.2. During the 7 days between
bovine heart acquisition and imaging, the tissue was sealed and stored in a refrigerator at 0◦C.
Once assembled with the physical design, the container was filled with water, submering the
stained bovine valve. This introduced hydrodynamics and ensured compatibility of the bovine
phantom with both CT and TEE imaging. The bovine valve was used primarily for a qualitative
analysis of image quality. This configuration is compatible for imaging in both air and water
to for the study with simultaneous TEE imaging for validation, as presented in Chapter 3.
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Figure 2.2: Preparation of the stained bovine mitral valve phantom (a) entire bovine heart (b) dissected
mitral valve leaflets, chordae and papillary muscles (c) annulus sutured to silicone flange (d) papillary
muscles sutured to strings (e) side view of stained valve submerged in water (f) apical view of the stained
bovine valve with strings sutured in the papillary muscles
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Motorized Valve Manipulator
We constructed a motorized system that provides repeatable, ECG-gated, realistic valve move-
ments over a complete cardiac cycle. The apparatus comprises two Arduino-controlled
(https://www.arduino.cc) servomotors (HiTEC, https://www.hitecrcd.com, HS-625MG), strate-
gically positioned pulleys for adjusting the papillary muscles, and chordae to open the valve
leaflets. The first prototype of the motorized valve manipulator consisted of two Faulhaber
motors and incremental encoders (2224U012SR, https://www.faulhaber.com/en/home/) used
to manipulate the leaflet positions. However, due to the limited capabilities of the motion man-
ager software for imaging off-site, we decided to revist motor options for the second prototype.
For the second iteration, servomotors were selected over Direct Current (DC) motors to ensure
precise control of the quasi-static valve model by modulating their angular position. The un-
modified servos used for this system have a fixed range of rotation from 0◦ to 180◦ and control
is achieved by sending a pulse of a particular length and duration to reach the desired position.
The Adafruit Motor Shield v2.3 (https://www.adafruit.com/) was soldered, assembled and in-
terfaced with the Arduino to utilize the built-in servo command library for streamlined position
control. Servos typically draw more current than the Arduino can supply, so we added a 24V
external power supply to run the motors [7].
The system mimics the full range of cardiac motion from diastole to systole. For heart
rates below 80 bpm (around most resting heart rates), the length of one cardiac cycle is ap-
proximately into the two phases as follows: one-third of the time in systole and two-thirds
in diastole [58]. For higher heart rates (greater than 80 bpm), the proportion of time spent
in diastole shortens as ventricular filling occurs over less time. This translates to mitral valve
motion which is gradual opening (diastole) and fast closing (systole), where the valve ”snaps
shut”. The motorized valve manipulator was programmed to operate at 30, 60 and 90 bpm. In
order to modulate the valve leaflets similar to their motion pattern in vivo, the four chords were
paired (one attached to each leaflet) and wrapped around the pulleys and attached to the lever
arm on the end of both servomotors. Initially in the position corresponding to 0◦ (the systole
phase, leaflets are closed, Figure 2.1), as the servomotors rotate clockwise to 90◦, the lever arm
pulls the chords which subsequently open the leaflets. When the servomotors reach 90◦, the
valve is in full diastole (leaflets are open, ventricular filling occurs, Figure 2.3).
Chapter 2. Accuracy of mitral valve imaging in dynamic 4D-CT 39
Figure 2.3: Silicone valve open at peak diastole and flange secured in 3D-printed stand mimicking pa-
tient lying supine with chords connected to pulleys and servomotors in the Arduino-controlled motorized
valve manipulator. Servomotors both at 90◦ angle position.
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For 30 and 60 bpm, the period or length of the cardiac cycle is 2s and 1s, respectively
with 2/3rd of the period in diastole and 1/3rd of the cycle in systole. For 90 bpm, the period
of the cardiac cycle is 0.667s and the ratio between length of diastole and systole decreases
to roughly 3/5th and 2/5th, respectively [18]. The parameters used to program the servomotors
and the Adafruit shield were the cardiac cycle length (or period) and the fraction of time spent
in diastole and systole. Valve motion was modulated by the servomotor-controlled lever arms
rotating from 0◦ to 90◦ continuously over the length of diastole (valve leaflets opening) and
from 90◦ to 0◦ rapidly over the length of systole (valve leaflets snapping shut). The angular
position and speed of the servomotors were controlled using the pos() and microseconds()
commands built-in with the servos library. The millis() command was used to keep track of
time in lieu of the delay() command, which is a global blocking function. For dynamic scans,
the motors operate continuously to mimic valve movement at either 30, 60 or 90 bpm As
the motorized valve manipulator was operated, the string-chordae were adjusted to simulate a
realistic systolic-to-diastolic valve motion pattern.
The final design constraint for the motorized valve manipulator is precise, repeatable arrest-
ing of the valve phantoms at specific time points. This function is necessary for constructing
the static ground truth images which are compared to the phase-matched images acquired dur-
ing the dynamic, continuous scan to determine the accuracy of the 4D-CT for dynamic mitral
valve motion. The six time points selected for static imaging (corresponding to the cardiac cy-
cle and ECG wave, Figure 2.4) were chosen according to stages of transition or movement of
the valve from one position to another. The time points span the R-R interval, and correspond
to precise servomotor angular positions which arrest the valve leaflets in particular positions.
With the anglular positions controlled in the static scans, we were able to correlate the static
volumes to the phase-matched volume acquired in the continuous, dynamic scan for 30, 60 and
90 bpm.
ECG Gating
ECG gating was used to phase-match the dynamic and static scans, acquired retrospectively.
An output gating signal (5V, 32ms square wave) from the Adafruit Motor Shield coincid-
ing with the R-wave of the cardiac cycle of the motorized valve manipulator connects to a
commerically-available Passive ECG Adapter (Model PI-ECG1 ver 1.3 PROT, Shelley Medi-
cal Imaging Technologies, London ON,
http://www.simutec.com/) with a Bayonet Neill-Concelman (BNC) cable. This device converts
the 5V square wave to a real QRS complex which is recognized by both the Revolution CT and
Philips iE33 TEE machine, analgous to ECG-gating for patient scans. With gated acquisition
of dynamic images, we could conduct phase-matching between static and dynamic scans.
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Figure 2.4: ECG wave with six corresponding time points selected for static ground truth images and
photos of the valve leaflet orientation at each position
Overall, this methodology provided us with two quasi-static phantoms for TEE and CT
image collection of both static and dynamic scenarios. From this we conducted two imaging
studies: (1) an analysis of the 4D-CT for capturing the mitral valve motion, with comparison
between dynamic and static, ground truth scans and (2) validation of TEE for mitral valve
imaging with simultaneous CT and TEE image acquisition, with the CT datasets used a ground
truth for comparison.
2.2.3 Image Acquisition
To provide ground-truth images, this phantom can be arrested at distinct points over the cycle
for comparison with a continuous, dynamic scan from both CT and ultrasound. For both the
silicone and bovine valve phantoms, 4DCT data were acquired with parameters appropriate for
maximum temporal resolution and image quality. The static ground truth dataset was acquired
first, followed by a continuous, restrospective scan of two dynamic cardiac cycles. The sili-
cone phantom was first imaged (static and dynamic) in air, and then the container was filled
with water for a second set of scans. The stained bovine valve was submerged in water for the
entire length of the scanning. In preparation for the TEE validation study performed in Chapter
3, simultaneous TEE and CT images were acquired of both the silicone and bovine valves. All
of the 3D TEE scans were acquired using a Philips iE33 (Philips, Amsterdam, NL), using the
X7-2t transesophageal probe. Three strategically placed holes on opposite sides of the annulus
served as fiducials that were visible in both CT and TEE for landmark-based registration. The
4D-CT scans were conducted on the GE Revolution Discovery multi-slice scanner (GE Medi-
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cal Systems, Waukesha, WI) for the cardiac protocol in cine mode at a resolution of
512 x 512 x 1792 and the pixel spacing of 0.398 x 0.398 x 0.398mm. These data were acquired
with retrospective gating and the scan parameters were set as follows: 120 keV, 120 mA, 0.28 s
gantry rotation, 2.2 s length of scan and 0.625 mm slice thickness. Each image reconstruction
used data acquired from a full 360◦ rotation of the gantry. The experimental setup is depicted
in Figure 2.5.
Acquisition of ground-truth static dataset
To establish a ground truth dataset, we acquired static images at different phases of the cardiac
cycle. Over the R-R interval, the valve was adjusted by the motorized system and arrested
at six chosen time points before acquiring a static image in the dynamic CT scanner (Figure
2.4). To do this, the silicone mitral valve phantom attached to the motorized valve manipulator
was programmed to adjust the angular position of the servomotors to a predefined location and
arrest the valve in position for 5s. During the pause, a 3D-CT volume was acquired. Then the
lever arm was adjusted to the next angular position, and another image was acquired. This step
was repeated until six static CT images were acquired, corresponding to distinct points over
the cardiac cycle. Once completed, the motorized valve manipulator components were moved
to the container with the submerged bovine valve phantom and the scanning was repeated.
Acquisition of continuous, phase-matched, dynamic dataset
After acquisition of the static ground-truth images, the silicone phantom in air within the mo-
torized valve manipuator was actuated continuously. This enabled acquisition of 3 sequential
dynamic scans with uninterrupted, ECG-gated mitral valve movement at 30, 60 and 90 bpm,
respectively. Two cardiac cycles were imaged for each heart rate. The phases of the images
acquired throughout this dynamic sequence correspond to the same phases provided by the
quasi-static ground truth series. Next, the container was filled with water and three scans were
acquired at 30, 60 and 90 bpm. Upon completion, the components of the motorized valve ma-
nipulator were attached to the submerged, bovine mitral valve phantom and three cine mode
scans were acquired at 30, 60 and 90 bpm.
Acquisition of simultaneous TEE and CT datasets
To use the 4D-CT scans of the mitral valve phantoms as ground truth in the TEE validation
study, simultaneous imaging with TEE and CT was performed. First, the submerged silicone
valve phantom and motorized valve manipulator was placed within the CT gantry with a TEE
probe positioned and secured at the esophageal view. Dynamic scans at the three different heart
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rates were acquired. The same protocol was repeated with the submerged, stained bovine valve
phantom and motorized valve manipulator.
Figure 2.5: The GE Revolution Dynamic CT with the submerged, stained bovine valve in the scanner,
Passive ECG Adapter device and the Arduino-controlled motorized valve manipulator
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2.2.4 Image Processing and Analysis
After acquisition, the image data were processed for a quantitative assessment of the match
between the static ground truth and the continuously-acquired scans. In addition, the image
quality of the dynamic scans was evaluated for common CT artifacts such as streaking, and
artifacts unique to 4D-CT such as duplicate, overlapping and incomplete structures.
Quantitative comparison and validation
For post-processing analysis, we applied the same pipeline to the three dynamically-acquired
scans (with 30, 60 and 90 bpm heart rates) with the silicone mitral valve phantom imaged in
air. The data from each scan was sorted and organized into six 3D volume pairs, matching
the images based on the ECG-gating and angular rotation of the servomotors for each precise
time-point. The six ground truth, static CT volumes were then aligned to the correspond-
ing phase-matched dynamic CT scan at each time-point by homologous-point landmark-based
registration in 3D Slicer 4.6.2 (https://www.slicer.org/). The fiducial landmarks used for this
registration were the three 2mm-diameter holes punched around the silicone flange annulus.
Next, both the anterior and posterior valve leaflets and chordae were segmented in MATLAB
(https://www.mathworks.com/products/matlab.html) by continuous max flow [60] for each CT
volume comprising the six phase-matched pairs for all three simulated heart rate scans. The
segmented leaflets and chordae for each phase-matched pair were overlaid in CloudCompare
(https://www.danielgm.net/cc/). This software platform was used to compute the mean Eu-
clidean distance between the static and dynamic geometries for each time-point, in all three
scans. The entire methodology for phantom assembly, image acquisition, image processing
and analysis is presented in Figure 2.6.
Qualitative image artifacts
The second component of the analysis of dynamic 4D-CT for mitral valve imaging was a qual-
itative assessment of image quality and identification of any image artifacts that may corrupt
the dyanmic datasets. These components were determined upon careful visual inspection of
the 2D slices within a 3D CT volume from the original 4D-CT reconstruction of simulated 30,
60 and 90 bpm heart rates for both the silicone and bovine valves submerged in water. This ex-
perimental setup was chosen as the aqueous environment more closely matches human cardiac
physiology than the silicone valve imaged in air.
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Figure 2.6: Workflow of methodology for silicone and bovine valve phantom assembley, image acquisi-
ton, image processing and image anaylsis
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2.3 Results
With this methodology, we constructed two mitral valve phantoms and a motorized valve ma-
nipulator which was capable of simulating realistic valve morphology over a range of heart
rates. In addition, the valve phantoms could be arrested at distinct time-points over the cardiac
cycle for construction of a static CT ground truth. These 3D volumes comprising the ground
truth were compared with the corresponding dynamic volumes from the matching time-points,
in order to determine the level of accuracy with which the dynamic CT captures mitral valve
movement. We also assessed the dynamic valve phantom scans qualitatively, with a focus on
motion artifacts which could corrupt or misconstrue structures within the images.
2.3.1 Quantitative comparison and validation
The phase-matched static and dynamic datasets were first aligned according to their corre-
sponding time points. Figure 2.7 presents a side-by-side comparison between slice 656 (out of
1792 in the volume) of the silicone valve phantom, imaged in air and captured at time-point
number four (Figure 2.4), with the valve in the pre-diastole position. Upon visual inspection
there were some minor difference between the statically-aquired image (Figure 2.7a) and the
image acquired dynamically with the motorized valve manipulator operating to simulate 60
bpm (Figure 2.7b). The differences were mainly localized to the positions of the chordae, since
these structures have the largest and most rapid motion during the phantom cardiac cycle.
Figure 2.7: 2D slice (z = 656 out of 1792) through the leaflets of the silicone valve, imaged in air
at 60 bpm captured at time-point 4 of the matched (a) static, ground truth dataset and (b) dynamic,
continuously-acquired images
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Our metric of quantitative comparison was the Mean Euclidean Distance (MED) computed
between the phase-matched static and dynamic geometries in CloudCompare. This served
as a metric of how accurately the continuous, dynamically-acquired scan captured the actual
valve position at distinct points over the cardiac cycle. Generally, the MED for the 30, 60
and 90 bpm scans of silicone in air were relatively small, indicating that the continuous scan
provides an accurate view of the valve in motion. For the higher heart rate of 90 bpm, the MED
was larger than for slower movements at 30 and 60 bpm. The maximum MED between two
phase-matched volumes at any of the six time points from the 90 bpm dataset was 3.55 mm,
showing that the dynamically-acquired scan closely matches the corresponding ground truth.
The regions of greatest difference between the static and dynamic volumes were predominately
around the chordae (Figure 2.8).
Figure 2.8: Distribution map of mean euclidean distance between phase-matched geometries segmented
from static and dynamic scans of the silicone valve phantom imaged in air with simulated 60 bpm. The
colour variation represents the increasing distance in mm between the two aligned geometries
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2.3.2 Qualitative image artifacts
The second part of the analysis of the dynamic CT scans of the valve phantoms was a qualitative
assessment of image artifacts. Overall, there was significant corruption of slices within 4D
volumes acquired at 60 and 90 bpm due to motion artifacts. Most common was the duplicate
structure artifact (Figure 2.9) where one or both of the leaflets appears twice on the image,
making the correspondance to the actual leaflet position ambiguous. The general trend was
that with larger and more rapid the motion of the valve leaflets and chordae (as simulated heart
rates increased), the more prevalent motion artifacts appeared within the individual slices. In
addition, the bovine valve presented a unique streaking artifact due to the stained papillary
muscle motion (Figure 2.10).
Figure 2.9: Example of duplicate leaflet structure image artifact found in one slice of 4D volume from
dynamically-acquired scan of the silicone valve in air
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Figure 2.10: Example of streaking artifact due to stained papillary muscle movement within one slice
of 4D volume from dynamically-acquired scan of the stained bovine valve in water operating at 30 bpm
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2.4 Discussion
The primary motivation of this work was to investigate whether 4D-CT could be used as a
ground truth to validate 3D reconstructions of the mitral valve from ultrasound. Dynamic
cardiac CT is emerging as a modality well suited to provide high quality images capturing
subvalvular anatomy and valve morphology over many cardiac phases. In order to assess the
accuracy of dynamic CT for mitral valve imaging, we propose a workflow to compare gated,
static CT images with phase-matched, dynamically-acquired images. In the work we showed
that dynamic CT is reliable for imaging the beating mitral valve in a phantom.
The goals of this chapter were to explore the potential of dynamic CT for imaging a dy-
namic mitral valve phantom. To evaluate this, we designed two mitral valve phantoms (silicone
and stained bovine) and constructed a motorized valve manipulator which simulates a range of
physiologic heart rates, with the ability to arrest the valve at discrete points in the cardiac
cycle. During image acquisition, we optimized parameters for the best possible temporal reso-
lution, with the hope of fully capturing valve motion at the higher heart rates when movement
became more rapid. We used mean euclidean distance (MED) as the metric for comparison
between the static, ground truth datasets and the phase-matched volumes from the continuous
scan. This gave us information about the ability of dynamic CT to accurately capture, represent
and display the underlying valve movement at these different heart rates. Generally, we found
good agreement between the static and dynamic volumes when the continuous scan captured
30 bpm, with the most discrepancy at the chordae positions. This is reasonable, as the chordae
move the most in this experimental setup. As the simulated heart rate increased, the ability
of the dynamic CT to accurately capture valve movement (as assessed by the MED between
ground truth and dynamic volumes) declined. In addition, we wanted to investigate to what
extent (if any) the image quality of the 4D-CT scans of dynamic mitral valve phantoms was
affected. At simulated heart rates of 30 bpm, we found minimal to no artifacts in the result-
ing images. However, for 60 and especially at 90 bpm, there were nontrivial artifacts, mainly
duplicate leaflet structures corrupting the images.
Dynamically-acquired, continuously-scanned volumes closely matched their phase-matched,
static, ground truth counterparts. However, qualitatively we observed a high degree of motion
artifacts–predominately duplicate structures–introduced with the dynamic scans. This effect
became more pronounced as the simulated heart rate increased to the range typical of patients
with valve regurgitation. However, improvements to the scanner itself are expected by next
year where the temporal resolution will change from 280 ms to 80 ms, and this change alone
could have a substantial impact on reducing artifacts. An observation unique to the bovine
valve was the addition of streaking artifacts due to the papillary muscles. This indicates a spe-
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cial consideration if extending this modality to valve imaging in humans where the presence
of other organs could also introduce new artifacts. Still, CT for mitral valve disease patient
use may be impractical since contrast-agent is required to provide contrast between valve and
blood.
To conclude, the valve manipulator at 30 bpm with both silicone and bovine valves can
serve as a ground truth phantom for a validation study with TEE. This work has demonstrated
the ability of dynamic CT to serve as ground truth for TEE validation in the study performed
and reported in Chapter 3 of this thesis.
Chapter 3
Accuracy of TEE for Mitral Valve
Imaging
This chapter is largely based on the paper:
• “How accurately does transesophageal echocardiography identify the mitral valve?” Ac-
cepted for presentation at Statistical Atlases and Computational Modelling of the Heart
(STACOM), a MICCAI Workshop in September 2018 in Granada, Spain and for publi-
cation in the IET Digital Library: Healthcare Technology Letters
3.1 Introduction
Due to the significant increase in life expectancy over the past century, valvular heart disease
has come to the forefront of challenges facing modern medicine [12]. Mitral valve disease
(MVD) classifies a range of different pathologies that cause regurgitation of blood into the
left atrium during ventricular contraction. Mitral valve regurgitation (MVR) can occur from
multiple pathologies, including prolapsed valves, as well as in the presence of flail leaflets
with ruptured chordae tendineae [2]. Transesophageal echocardiography (TEE) is currently
the state-of-the-art technique for diagnosis and evaluation of MVD. A diseased valve presents
with regurgitation of high velocity blood which can be visualized with the TEE probe under
Doppler [15]. Once diagnosed, a plan for intervention is decided upon based on patient’s age,
anatomy and in some cases additional cardiac computed tomography (CT) imaging. At present,
this is a largely subjective process based mainly on images and clinician experience. There are
limitations to using TEE for diagnosis and intervention of regurgitant mitral valves. A study of
242 patients who underwent TEE-guided mitral valve repair for degenerative MVD found the
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rate of recurrence of regurgitation to be 5% after 1 month and 40% after 4 years [19].
Personalized analytical cardiac models have become a crucial component of the clinical
workflow, especially with complex disorders such as valvular heart disease [39]. Patient-
specific modelling provides an unparalleled opportunity for pre-operative planning and prac-
tice. The development of image-guided procedures enables minimally-invasive, beating-heart
surgery, but poses new challenges and risks by removing the clinician’s direct line of sight [46].
The success of these interventions relies on patient-specific simulators for pre-operative plan-
ning, including attempting different access routes, deployment of sutures and analyzing their
accuracy, navigating variations in patient anatomy and repeating the procedure under image-
guidance to reduce the cognitive load when performing the actual operation. Currently, the
development of these models is limited by the quality of the patient images from which they
are modelled. The mitral valve is segmented from a patient’s diagnostic TEE, and rendered as a
volume for rapid prototyping into a tissue-mimicking valve [24]. However, multiple pervading
issues with the TEE datasets challenge the valve segmentation and successful implementation
of this protocol. The first is the prevalence of signal dropout, appearing as gaps within the valve
leaflet in regions that should present as contiguous tissue. For diagnosis, images corrupted by
artifacts limit the clinicians’ ability to determine the cause of regurgitation; for modelling, the
valve cannot be completely segmented and the resulting models have holes. This results in
a loss of some patient-specific morphology and the efficacy of the models is decreased. The
second issue is the presence of high-intensity signal artefacts that appear in the TEE images
and can be misconstrued as leaflets or other anatomical structures [40].
While an accurate valve segmentation of 3D TEE images is needed for patient-specific
modelling, it is also a valuable diagnostic tool. Quantitative analysis is an integral part of the
overall assessment of valve morphology and gives objective evidence for both classification
and guiding intervention of regurgitation [23]. Current commercial 3D TEE imaging platforms
can derive quantitative measurements and 3D visualizations of annular and leaflet geometry
[56]. The software used for valve quantification and segmentation available from most ven-
dors is semi-automated. Clinicians can calculate valve surface area, commissure-commissure
lengths and leaflet area to identify various pathological features, evaluate MVR severity and
inform subsequent interventions and treatment. Measurements made to evaluate lengths for
neo-chordae, valve replacements and other volumetric data rely on intensities in TEE images
as indications of valve and papillary muscle tissue [17]. Quantitative measurements and as-
sessment is an essential step in the evaluation of patient-specific geometry, pathophysiologic
mechanisms and abnormalities of the mitral valve.
The major challenge with 3D TEE segmentation is that a limited number of methods exist
that can accurately and robustly isolate the mitral valve. These techniques vary in the extent
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Figure 3.1: A 2D slice of a 3D TEE volume that demonstrates the two different ways to estimate the
boundary (depicted in red). The edges of the bright intensity regions in valve TEE images are ambiguous
and it is unclear if they are due to echoes or represent underlying valve tissue.
of user interaction required. Several anatomical details of the valve introduce nontrivial chal-
lenges to its segmentation. First, there is no intensity-based boundary between the leaflets and
the adjacent heart tissue, which makes it difficult to identify the leaflet boundaries and annu-
lus solely with image intensity information. As well, during diastole, the posterior leaflet is
often pressed against the left ventricular wall, and the resulting echo image is characterized
by signal dropout; this poses a challenge for an automated segmentation algorithm to capture
the posterior leaflet geometry when the valve is opened. In addition, there is no intensity-
based distinction between the anterior and posterior leaflets, and it is difficult to distinguish
the coaptation zone during systole [56]. The majority of current ultrasound segmentation tech-
niques involve and rely on intensity thresholds. Methods include intensity-based level sets,
active contours graph cuts and thresholding to segment the valve [53]. However, it remains
ambiguous whether regions of high intensity correspond to presence of mitral valve or papil-
lary muscle tissue. As demonstrated in Figure 3.1, the leaflet boundaries are ambiguous, and an
intensity-based approach cannot always accurately delineate the valve. Along the appearance
of the tissue edge in particular, there is the option to over- or under-estimate the leaflet with
intensity-based segmentation.
The goal of the present work is to evaluate the relationship between intensity values in
3D TEE images and underlying valve structure as seen in CT. This will inform intensity-
based techniques for valve segmentation used in diagnosis, quantitative assessment and patient-
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specific modelling of mitral valve regurgitation. To accomplish these goals, we propose the
creation of ground truth CT datasets of silicone and bovine valve models for comparison to
simultaneously acquired TEE images.
3.1.1 Contribution
The main contribution of this work is its analysis of the relationship between TEE intensities
and underlying mitral valve tissue. With comparison to a CT ground truth, we have quantified
the observed overestimation of valve structure in TEE [10]. Further, we have explored and
demonstrated the efficacy of the centre line method for improved valve segmentation.
3.2 Materials and Methods
3.2.1 Overview
To meet the objectives of this study, our task was two-fold. First, we created a ground truth for
mitral valve TEE image segmentation in both static and dynamic settings. Second, we employ
this ground truth dataset to study the correspondence between mitral valve TEE image intensity
distribution and the underlying valve morphology.
3.2.2 Ground Truth Creation
The silicone and bovine phantoms described in Chapter 2 were used, with both containers filled
with water. An important requirement for creation of the ground truth dataset is simultaneous
imaging of the mitral valve phantoms with CT and TEE. Because of CT’s high resolution
capability, we used the segmented valve from the CT image as the ground truth for comparison
with the TEE images.
Image Acquisition
The data were acquired with simultaneous CT and TEE imaging of both the silicone and bovine
valves. All of the 3D TEE scans were acquired using a Philips iE33 (Philips, Eindhoven, NL),
using the X7-2t transesophageal probe. Three strategically placed holes on opposite sides
of the annulus served as fiducials that were visible in both CT and TEE for landmark-based
registration. The resulting dynamic image used for post-processing is an average over multiple
TEE acquisitions. To create the static ground truth, the CT images were acquired in an O-arm
(Medtronic, Minnesota, MN) at a resolution of 512 x 512 x 120 and the pixel spacing of 0.415
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Figure 3.2: Pipeline for image acquisition, image processing and statistical analysis.
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x 0.415 x 0.833mm. As outlined in Chapter 2, to obtain the dynamic ground truth, the 4D-
CT scans were performed on the GE Revolution Discovery multi-slice scanner (GE Medical
Systems, Waukesha, WI) in cine mode. These data were acquired with retrospective gating and
the scan parameters were set as follows: 0.28 s gantry rotation, 2.2 s length of scan and 0.625
mm slice thickness. Each image reconstruction used data acquired from a full 360◦ rotation of
the gantry.
Image Processing
Following acquisition, specific images were selected for further analysis based on visual in-
spection. Due to the poor image quality of TEE images during systole, this primarily consisted
of selecting eight CT-TEE cardiac phases from end-diastole. In addition, we chose to use im-
ages with the motorized valve manipulator described in Chapter 2 operating at 30 bpm to avoid
duplicate structure artifacts where a valve leaflet appears twice in one reconstructed slice in
4DCT. Once selected and sorted into image pairs, corresponding time frames were registered.
The CT-TEE registration process was not trivial; to ensure a high degree of accuracy, most
of the registration was performed manually. First, we placed landmarks in the centres of the
holes visible in both CT and TEE, and the landmark-based registration was performed to act
as a good initialization for CT-TEE registration. We then employed the BRAINS registration
module in Slicer 4.6.2 (https://www.slicer.org/) to improve the alignment. Using this module,
we implemented both Mutual Information (MI) and Normalized Cross Correlation (NCC) as
our registration metrics, with NCC providing the more accurate alignment based on visual in-
spection. After automatic registration using NCC, the alignment was manually fine-tuned to
further improve the registration accuracy. The aligned TEE and CT images were then apodized
manually to focus on the valve region and to exclude the silicone flange and other supporting
apparati that are also visible in the TEE and CT images. Finally, we applied the continuous
max flow [72] algorithm to segment the processed CT images for subsequent use as ground
truth. The workflow of the proposed ground truth creation pipeline is represented in Figure
3.2.
3.2.3 Image Analysis
With the ground-truth correspondence and registration established, we then completed both
intensity-based and segmentation-based analyses of the static silicone (1 image pair), dynamic
silicone (8 image pairs) and dynamic bovine (8 image pairs) CT segmentation and TEE image
pairs.
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Pixel based analysis
First, we directly studied the relationship between TEE image pixel intensity and the likelihood
that a pixel belongs to the leaflet. Thus, for each discretized pixel intensity i ranging from 1 to
255, we computed the conditional probability of a pixel belonging to the valve region given its
intensity by the following equation:
P(i) = P(x ∈ L|I(x) = i) = P(x ∈ L ∩ I(x) = i)
P(I(x) = i)
, (3.1)
where P(I(x) = i) represents the probability that a pixel in TEE images has intensity i,
P(x ∈ L) represents the probability that a pixel at location x belongs to the leaflet, and P(x ∈
L ∩ I(x) = i) represents the probability of the joint event. Thus, for any pixel location x, it can
be determined if it is included in the leaflet by computing the dot product with the aligned CT
segmentation at the same location x.
Segmentation based analysis
To further analyze the intensity correspondence of the TEE intensities and valve tissue, we
also studied the performance of an advanced and commonly-used intensity-based segmentation
approach. Aside from an optimization parameter, the two user inputs are a lower and upper
threshold, which anticipate the intensity values of the background and foreground, or valve,
respectively. Since we are interested in correctly predicting the location of the leaflet based
on intensity, we used the positive predictive value (PPV) as our measurement of segmentation
accuracy. This accounts for the fact that the majority of the TEE image is background, while
we are concerned with correctly identifying valve regions. In the context of Receiver Operating
Characteristic (ROC), the PPV is given as:
PPV =
T P
T P + FP
, (3.2)
where TP represents the true positive rate and FP represents the false positive rate. Using this
metric, we examined the PPV of the 3D continuous maxflow (3D CMF) algorithms. We ran
the algorithm multiple times with different intensity threshold values for a thorough analysis
of any improvements due to threshold optimization.
Centre-Line based analysis
From past observations, we noticed that the leaflets shown on TEE images were always thicker
than those presented in CT. This could be an indication that the classification errors were mainly
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located near the edges of the TEE segmentations, while the centre of the intensity-based seg-
mentation is more likely to be part of the leaflet. Thus, as a preliminary study, we wanted
to test a hypothesis that using the centre line of the TEE segmentation to represent the mitral
valve is more accurate than using the segmentation surface to represent the valve surface. To
test this hypothesis, we first computed the segmentations of the static silicone, dynamic sil-
icone and dynamic bovine TEE images using the 3D CMF algorithm and then extracted the
centre-lines from both TEE segmentations and CT segmentations. Then we compared the root
mean squared distances between the surfaces of TEE and CT segmentations and the distance
between TEE and CT centre-lines.
3.3 Results
In this study, we created a dynamic silicone phantom and a dynamic bovine phantom, which
allowed us to image them in both static and dynamic states. Following the registration scheme
shown in Figure 3.2, we created three sets of CT ground truth images for static silicone TEE,
dynamic silicone TEE, and dynamic silicone TEE. For each dataset, we performed the pixel-
and segmentation-based analyses as described in Section 3.2. Finally, we performed a center-
line analysis using the static silicone dataset, as a pilot study, to prove the validity of our
hypothesis given in Section 3.2.
3.3.1 Pixel based analysis
For each dataset, we computed the conditional probability of a pixel belonging to the valve
region given its intensity following equation (1). The relationships between the likelihood and
the TEE image intensity are shown in Figure 3.3. Generally, the results indicate that even with
an optimized naive based threshold segmentation, only 40% of pixels are correctly classified
as part of the valve.
The results shown in Figure 3.3 indicate the likelihood of any individual pixel intensity
value corresponding to part of the valve. In Figure 3.3(a), we see that for the static silicone
valve, there is a maximum 42% likelihood that any pixel would be classified as valve tissue,
given its TEE intensity. From Figure 3.3(b), the maximum likelihood of intensity-based valve
classification for the dynamic silicone valve is 35%. For the dynamic bovine valve, the max-
imum likelihood given its intensity is below 51%, as shown in Figure 3.3(c). As a result, our
data suggest that classification based on intensity alone may be error-prone and subject to false
positives.
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Figure 3.3: Plots of probability of each individual pixel intensity value in TEE images to correctly
classify the pixel as part of the valve leaflet for (a) static silicone valve model (b) dynamic silicone valve
model and (c) dynamic bovine valve model
3.3.2 Segmentation based analysis
After the pixel-based analysis was completed, we performed a 3D Continuous Max Flow
(CMF) segmentation [72] on all three image pairs (static silicone, dynamic silicone and dy-
namic bovine). CMF is an advanced, intensity-based segmentation technique that needs both
a lower and upper threshold to indicate the expected intensity value of the background and
foreground, respectively.
The results from the 3D CMF segmentations are depicted in Figure 3.4. The multiple
coloured lines represent the range of options for the lower threshold, and upper threshold varies
along the x-axis. The algorithm begins with the initial lower threshold (the x-intercept) and
runs through a search of all possible upper threshold values. Each line represents a different
initial expected value for the background, and together these lines map all the possible com-
binations of lower and upper thresholds for 3D CMF. The y-axis includes the PPV value for
each combination of lower and upper thresholds. Here, we investigated if any combination of
user-defined parameters could optimize the segmentation accuracy.
From Figure 3.4(a), the maximum PPV is 40% for the 3D CMF segmentation of the static
silicone valve. In Figure 3.4(b), the maximum PPV value is 31%, calculated over 8 averaged
dynamic silicone volumes. Finally, in Figure 3.4(c), the 3D CMF segmentation of the dynamic
bovine model yields a maximum averaged PPV value of 49%. Given that this is an advanced
and commonly used technique for mitral valve segmentation, these results highlight the limi-
tations of an intensity-only approach [60]. Thus, regardless of user-defined thresholds, mitral
valve segmentation is limited by relying solely on intensity values of the ultrasound images.
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Figure 3.4: Plots of positive predictive value (PPV) for a range of lower and upper intensity thresholds
for segmentation using 3DCMF of (a) static silicone valve model (b) dynamic silicone valve model and
(c) dynamic bovine valve model. The coloured lines indicate different lower threshold values for a range
of upper threshold values, tracked along the x-axis.
3.3.3 Centre-line Based Analysis
Following the description in Section 2.2, we performed a centre-line analysis on the static
silicone image pairs. As an example, the overlayed 2D sections are shown in Figure 3.5,
where Figure 3.5(a) demonstrates the overlayed centrelines and Figure 3.5(b) demonstrating
the overlaid segmentations. The CT segmentation and centre-line is shown as green and the
TEE segmentation and centre-line is shown in pink. As demonstrated by Figure 3.5(b), there
are large distances between the edges of the TEE and CT segmentations, while from Figure
3.5(a), the distance between CT and TEE centre-lines is significantly smaller. Quantitatively,
from 3D studies, the surface root mean squared distance (RMSD) between surfaces of the TEE
and CT segmentations is 1.80 mm whereas the RMSD between the centre-lines extracted from
the TEE and CT segmented volumes is 0.81 mm. Thus, these preliminary results support our
hypothesis that the center line of the TEE segmentation is a better representation of the valve
morphology than the solely intensity-based methods of leaflet edge delineation.
3.4 Discussion
Comprehensive visual and quantitative analysis of dynamic mitral valve morphology is neces-
sary for identifying and correcting regurgitation. TEE is widely accepted as the gold standard
for mitral valve imaging. The clinical workflow involves several applications of a mitral valve
segmentation for quantifying and modelling patient-specific parameters and behavior. Most
methods for valve segmentation are intensity-based, though it is unclear how the pixel values
present in a TEE image correspond to underlying valve tissue. In this study, we evaluated the
accuracy of TEE mitral valve imaging through construction of quasi-static silicone and bovine
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Figure 3.5: Overlaid segmentations of static silicone valve TEE (pink) and CT (green) images, and
complete agreement between them (white) a) with centre-line extraction from 3DCMF segmentation
and b) with 3DCMF segmentation only
valve phantom used to compare CT ground truth with simultaneously-acquired TEE images.
The results provide evidence that reliance on intensity alone for segmentation cannot fully cap-
ture the valve structure, quantified by probability and positive predictive value metrics. The
curves in Figure 3.3 present compelling evidence that individual pixel intensities in TEE do
not have a consistent and obvious correspondence to underlying tissue. Comparisons across
the three valve models (static silicone, dynamic silicone and dynamic bovine) demonstrate that
the segmentation of the dynamic bovine TEE with 3DCMF is more accurate than images made
with both static and dynamic silicone valves. This could indicate that individual pixel intensi-
ties in TEE images of biological tissue have a better correspondence to underlying structures
than in silicone models. As such, further studies should be performed incorporating patient
imaging data for a more comprehensive analysis of TEE for mitral valve imaging. The gen-
eral trend present across all graphs in Figure 3.3 is that higher intensity values have a higher
probability of identifying valve tissue. Although, with a maximum 50% likelihood of valve
classification at any intensity, these results are compelling and motivate the use of new segmen-
tation techniques that do not rely solely on intensities. Rather, valve segmentation should also
incorporate some level of shape information about the valve structure. We demonstrate this by
comparing an intensity-based segmentation with a centre-line analysis. These results demon-
strate the efficacy of augmenting an intensity-based segmentation with information about the
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shape and structure of the valve.
A limitation of this work is that the TEE images analyzed in this study were acquired from
an older generation ultrasound system. As the technology continues to improve, a similar anal-
ysis should be conducted on future systems. Furthermore, we constructed our ground truth
with the assumption that any motion artifacts due to valve motion in dynamic CT would be
negligible. In reality, the resulting images had streaking artifacts and duplicate structures, with
higher prevalence of artefact at higher simulated heart rates. To accomodate for and avoid these
motion artifacts in our ground truth images, we selected 4DCT data from the 30bpm valve sim-
ulation. In addition, the analysis was restricted to 3 pairs of images due to limited acquisition
time and TEE image quality. Further studies will evaluate a larger range of corresponding CT
and TEE images of valve models at different cardiac phases.
This work has the potential to both inform current techniques for TEE imaging and seg-
mentation as well as motivate the development of new methods for identifying valve structure
in TEE from known correspondence to ground truth CT images. In future, being able to pair
up ground truth CT images with actual TEE images may form the basis for improved recon-
structions from TEE data. With CT data as a labelled training set, deep learning techniques can
further extend this work to map between CT and TEE, and incorporate deep learning to predict
the TEE segmentation from pre-existing CT segmentations.
Chapter 4
Conclusions and Future Work
4.1 Conclusions
The purpose of this thesis was first to develop a methodology for the design, implementation
and assessment of a mitral valve phantom used to construct a dataset of ground truth images.
The second aim of this work was to use this ground truth phantom in a validation study of
transesophageal echocardiography imaging of the mitral valve. This thesis was as such divided
into two chapters following the objectives stated in Chapter 1. Overall conclusions from both
chapters will be discussed in this section.
In Chapter 2, our aim was to investigate whether 4D-CT could be used as a ground truth to
validate 3D reconstructions of the mitral valve from TEE. We outlined the design of two mi-
tral valve phantoms and construction of a motorized valve manipulator which simulates three
different ECG-gated heart rates and can arrest the valve at precise, pre-selected points over the
cardiac cycle. This has the ability to both inform and augment the use of TEE in mitral valve
imaging for diagnosis and pre-operative models used in planning and practice. The results re-
ported in Chapter 2 indicate that dynamic, 4D-CT has the potential to both extend and enhance
the imaging of the mitral valve and subvalvular apparatus. However, we discovered that with
simulated physiologic heart rates, the prevalence of motion artifacts increased such that du-
plicate leaflets and streaking both corrupted the resulting images. The phantom implemented
and analyzed in Chapter 2 had a direct impact on the experiment reported in the subsequent
chapter, from which more general conclusions can be drawn which are relevant to clinicians
and researchers.
In Chapter 3, we performed an experiment with simultaneous TEE and CT imaging for
a validation study. This primarily serves to validate the use of mitral valve segmentation in
the workflows for MVD diagnosis and patient-specific modelling. We have demonstrated that
reliance on intensity methods of segmentation alone do not closely identify underlying valve
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tissue. Rather, valve segmentation from ultrasound should incorporate some level of shape
information about the structure in addition to individual intensities. We hope that this will
assist clinicians and engineers in future applications of mitral valve segmentation. In addition,
this can be used to inform advanced techniques for classification of the mitral valve with deep
and machine learning.
4.2 Future Work
These techniques have the potential to enable clinicians to acquire information for a thorough
qualitative and quantitative assessment of regurgitant mitral valves. We have demonstrated that
dynamic CT is a valuable tool for imaging mitral valve phantoms as a means of validating the
use of transesophageal echocardiography in the clinical workflow for valvular disease. Current
techniques for TEE imaging and segmentation of the mitral valve are limited by the prevalence
of signal dropout, artifacts and limited field of view. One course of future direction will be
to apply the accuracy analysis and validation pipelines to imaging machines with upgraded
hardware and software. Within the next year, the Revolution CT will have an increased gantry
speed from 280ms to 200ms; this improved temporal resolution could reduce the prevalence of
image aritfacts at higher heart rates. Additionally, we plan to develop another prototype of the
quasi-static phantom with subvalvular components and more physiologically-relevant features
to improve the strength of these findings. With regards to the validation study in Chapter 3, we
plan to extend the results to derive a mapping function between the intensities from dynamic
CT and ultrasound in order to predict and inform the mitral valve segementation. Eventually,
this will be developed into a neural network for deep learning of the relationship between
dynamic CT and TEE, with a large database of patient images used to train the network for
diagnosis and segmentation of regurgitant valves.
Each focus of the future work is aimed to improve the clinical workflow for mitral valve dis-
ease from diagnosis, pre-operative planning and preparation to intervention and post-operative
monitoring. We have completed a novel, first-of-its-kind assessment of dynamic CT for this
application. Currently we have demonstrated some intriguing results for the role that dynamic
CT can play in the valvular disease workflow. We hope that this this thesis has laid the ground
work for a further investigation of dynamic CT for mitral valve imaging, such that furure re-
search can build on this work and continue to develop tools and systems which will improve
surgical outcomes for heart disease patients.
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